We first identified monogenic risk variants by sequencing the BRCA1 and BRCA2 genes in 1920 breast cancer cases and 17,344 controls, all female, from the Color Genomics commercial testing laboratory (Table 2)20. Here, BRCA2 is linked to breast cancer.